Bruker (BRKR)
(Delayed Data from NSDQ)
$80.97 USD
+0.38 (0.47%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $80.94 -0.03 (-0.04%) 7:58 PM ET
2-Buy of 5 2
C Value C Growth B Momentum C VGM
Price, Consensus and EPS Surprise
BRKR 80.97 +0.38(0.47%)
Will BRKR be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for BRKR based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for BRKR
Earnings Preview: Bruker (BRKR) Q1 Earnings Expected to Decline
Bruker (BRKR) Introduces Magnet Technology for NMR Adoption
BRKR: What are Zacks experts saying now?
Zacks Private Portfolio Services
Bruker Corporation (BRKR) Hits 52-Week High: What's Driving It?
Why Is Bruker (BRKR) Up 15.7% Since Last Earnings Report?
Bruker (BRKR) Up 20.7% Since Last Earnings: What's Driving It?
Other News for BRKR
Bruker Further Enhances Clinical Microbiology & Infection Diagnostics Portfolio at ESCMID Global 2024 Conference
Bruker Announces Date and Time of First Quarter 2024 Earnings Release and Webcast
Bruker Corporation: An Aggressive Acquisition Strategy
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Owens & Minor (OMI), Bruker (BRKR) and Gilead Sciences (GILD)
Bruker to Acquire the NanoString Business in an Asset Deal